Presentación    
RESPIRATORY DISEASES
Composition
Name
Position
Institution
Francisco José García Río
Jefe de Sección de Neumología (Contrato de Intensificación)
Profesor Titular. Facultad de Medicina
Hospital Universitario La Paz
Universidad Autónoma de Madrid
Cristina Aguado Cruz
Investigador Predoctoral
Hospital Universitario La Paz
Sergio Alcolea Batres
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Rodolfo Álvarez-Sala Walther
Jefe de Servicio de Neumología
Catedrático. Facultad de Medicina
Hospital Universitario La Paz
Universidad Autónoma de Madrid
Juan José Cabanillas Martín
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Carlos Javier Carpio Segura
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Raquel Casitas Mateo
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Carolina Cubillos Zapata
Investigadora Posdoctoral (Contrato Sara Borrell)
Hospital Universitario La Paz
Raúl Galera Martínez
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Luis Gómez Carrera
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
María Antonia Gómez Mendieta
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Elisabet Martínez Cerón
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
José María Pino García
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Concepción Prados Sánchez
Jefe de Sección de Neumología
Hospital Universitario La Paz
David Romero Ribate
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Ana Santiago Recuerda
Facultativo Especialista de Área en Neumología
Hospital Universitario La Paz
Carlos Villasante Fernández-Montes
Jefe de Sección de Neumología
Hospital Universitario La Paz
 
Strategic Objective
Our group studies the molecular mechanisms of cardiovascular morbidity associated with sleep breathing disorders, in particular, the sleep apnoeahypopnea syndrome(SAHS).
We also provide evidence for making clinical decisions on patients with these disorders. We conduct studies to evaluate the mechanisms involved in the development of arterial hypertension, arrhythmias, heart failure, ischaemic heart disease, pulmonary hypertension, pulmonary embolism, and carbohydrate metabolism disorders.
In terms of the pathogenesis of airflow limitations, several of our projects have focused on small airway function, bronchial hyperresponsiveness and exercise adaptation in a number of obstructive diseases, particularly COPD, asthma and cystic fibrosis. We also evaluate the objective measurement of daily physical activity in these patients and contribute to the best definition of its determinants and its clinical and prognostic usefulness. We collaborate with other research groups to study the contribution of the innate immune system to the evolution of these diseases and the relationship between the response to hypoxia and the clinical expression of COPD and SAHS.
Finally, in the field of the systematisation of lung function testing, we create reference values for various population groups and define the methodological aspects of the measurement of exhaled breath condensate and nitric oxide.
Research Lines
• Cardiovascular morbidity of sleep-disordered breathing
• Pathogenesis of airflow limitation
• Systematization of lung function testing